tirzepatide triple agonist Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Retatrutide vs Mounjaro: triple agonist

Mounjaro is a once-weekly tirzepatide injection used for weight loss in adults with obesity or weight-related conditions

Sleep quality improvements occur secondary to weight loss for both medications

Rotating injection sites weekly helps prevent lipohypertrophy (fatty lumps at the injection site) and maintains consistent absorption

36 The attachment of long fatty acids relayed by a carboxylic linkage leaves the affinity and activity almost unaffected

Moreover, Gly 35 , Arg 36 , and Gly 37 may contribute to selectivity of GLP-1

[DOI] [PubMed] [Google Scholar] 13.Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Pilitsi E, et al